$ANRO Balance Sheet | Understand Stock

$ANRO

$23.19 +$1.08 (4.88%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024
Assets
Current assets:
Cash and cash equivalents
Other receivables
Prepaid expenses and other current assets
Total current assets
Restricted cash
Property and equipment, net
Operating right-of-use asset
Other assets
Total assets
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Term loan, current
Total current liabilities
Term loan, non-current
Convertible Grant Agreement
Preferred stock warrant liability
Lease liability, long-term
Total liabilities
Convertible preferred stock
Stockholders’ equity:
Common stock (par value $0.0001), 500,000 shares authorized; 35,094 and 31,924 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments